• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重定向驱虫药可减轻高毒力静止期艰难梭菌。

Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile.

机构信息

Departments of Chemistry and Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and The Worm Institute of Research and Medicine (WIRM), The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.

出版信息

Sci Rep. 2016 Sep 16;6:33642. doi: 10.1038/srep33642.

DOI:10.1038/srep33642
PMID:27633064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5025651/
Abstract

Prolonged use of broad-spectrum antibiotics disrupts the indigenous gut microbiota, which consequently enables toxigenic Clostridium difficile species to proliferate and cause infection. The burden of C. difficile infections was exacerbated with the outbreak of hypervirulent strains that produce copious amounts of enterotoxins and spores. In recent past, membrane-active agents have generated a surge of interest due to their bactericidal property with a low propensity for resistance. In this study, we capitalized on the antimicrobial property and low oral bioavailability of salicylanilide anthelmintics (closantel, rafoxanide, niclosamide, oxyclozanide) to target the gut pathogen. By broth microdilution techniques, we determined the MIC values of the anthelmintics against 16 C. difficile isolates of defined PCR-ribotype. The anthelmintics broadly inhibited C. difficile growth in vitro via a membrane depolarization mechanism. Interestingly, the salicylanilides were bactericidal against logarithmic- and stationary-phase cultures of the BI/NAP1/027 strain 4118. The salicylanilides were poorly active against select gut commensals (Bacteroides, Bifidobacterium and Lactobacillus species), and were non-hemolytic and non-toxic to mammalian cell lines HepG2 and HEK 293T/17 within the range of their in vitro MICs and MBCs. The salicylanilide anthelmintics exhibit desirable properties for repositioning as anti-C. difficile agents.

摘要

长期使用广谱抗生素会破坏本土肠道微生物群,从而使产毒艰难梭菌得以增殖并引起感染。随着产毒能力更强的高毒力菌株的爆发,艰难梭菌感染的负担加剧了,这些菌株会产生大量的肠毒素和孢子。在最近,膜活性药物因其杀菌特性和低耐药倾向而引起了人们的极大兴趣。在这项研究中,我们利用驱虫药(氯硝柳胺、三氯苯达唑、硝氯酚、奥硝唑)的抗菌特性和低口服生物利用度来靶向肠道病原体。通过肉汤微量稀释技术,我们测定了驱虫药对 16 株确定的 PCR-核糖体分型艰难梭菌分离株的 MIC 值。驱虫药通过膜去极化机制广泛抑制艰难梭菌的体外生长。有趣的是,水杨酰苯胺类药物对 BI/NAP1/027 菌株 4118 的对数期和稳定期培养物具有杀菌作用。水杨酰苯胺类药物对肠道共生菌(拟杆菌属、双歧杆菌属和乳杆菌属)的活性较差,并且在其体外 MIC 和 MBC 范围内对 HepG2 和 HEK 293T/17 哺乳动物细胞系既非溶血也无毒。水杨酰苯胺类驱虫药具有作为抗艰难梭菌药物重新定位的理想特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/0d8f5aa4316d/srep33642-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/8936541b6e67/srep33642-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/5b80c5d69666/srep33642-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/0d8f5aa4316d/srep33642-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/8936541b6e67/srep33642-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/5b80c5d69666/srep33642-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/5025651/0d8f5aa4316d/srep33642-f3.jpg

相似文献

1
Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile.重定向驱虫药可减轻高毒力静止期艰难梭菌。
Sci Rep. 2016 Sep 16;6:33642. doi: 10.1038/srep33642.
2
Antimicrobial effects of Manuka honey on in vitro biofilm formation by Clostridium difficile.麦卢卡蜂蜜对艰难梭菌体外生物膜形成的抗菌作用。
Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1661-1664. doi: 10.1007/s10096-017-2980-1. Epub 2017 Apr 18.
3
Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.重新利用水杨酰苯胺类驱虫药来对抗耐甲氧西林金黄色葡萄球菌。
PLoS One. 2015 Apr 21;10(4):e0124595. doi: 10.1371/journal.pone.0124595. eCollection 2015.
4
Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model.评估头孢洛林对艰难梭菌的抗菌活性及其在体外人类肠道模型中诱导艰难梭菌感染的倾向。
J Antimicrob Chemother. 2013 Aug;68(8):1842-9. doi: 10.1093/jac/dkt107. Epub 2013 Apr 3.
5
Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.将驱虫药尼氯硝唑重新用于对抗幽门螺杆菌。
Sci Rep. 2018 Feb 27;8(1):3701. doi: 10.1038/s41598-018-22037-x.
6
The pharmacology of halogenated salicylanilides and their anthelmintic use in animals.卤代水杨酰苯胺类药物的药理学及其在动物体内的驱虫用途。
J S Afr Vet Assoc. 1999 Jun;70(2):61-70. doi: 10.4102/jsava.v70i2.756.
7
In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.舒罗霉素对西班牙分离的当代产毒艰难梭菌临床菌株的体外活性。
J Antimicrob Chemother. 2015 Aug;70(8):2311-5. doi: 10.1093/jac/dkv092. Epub 2015 Apr 15.
8
Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.2012年在波兰分离出的属于不同聚合酶链反应核糖体分型的艰难梭菌菌株的抗菌药敏模式。
Anaerobe. 2015 Feb;31:37-41. doi: 10.1016/j.anaerobe.2014.09.004. Epub 2014 Sep 19.
9
[Antimicrobial susceptibilities and molecular characterization of toxin-positive Clostridium difficile isolates: the first report on the presence of hypervirulent strains from Turkey].毒素阳性艰难梭菌分离株的抗菌药敏性及分子特征:来自土耳其的高毒力菌株存在情况的首次报告
Mikrobiyol Bul. 2017 Jul;51(3):236-246. doi: 10.5578/mb.57467.
10
Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile.舒罗霉素对生长中和非生长艰难梭菌的作用模式及杀菌特性
Antimicrob Agents Chemother. 2015 Sep;59(9):5165-70. doi: 10.1128/AAC.01087-15. Epub 2015 Jun 8.

引用本文的文献

1
Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.雷复尼特的新用途:从抗寄生虫药到抗癌药。
Biomedicines. 2025 Jul 9;13(7):1686. doi: 10.3390/biomedicines13071686.
2
Drug Repurposing: Research Progress of Niclosamide and Its Derivatives on Antibacterial Activity.药物再利用:氯硝柳胺及其衍生物抗菌活性的研究进展
Infect Drug Resist. 2024 Oct 21;17:4539-4556. doi: 10.2147/IDR.S490998. eCollection 2024.
3
New functions of pirin proteins and a 2-ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile.

本文引用的文献

1
Onchocerca volvulus Molting Inhibitors Identified through Scaffold Hopping.通过骨架跳跃鉴定出的盘尾丝虫蜕皮抑制剂。
ACS Infect Dis. 2015 May 8;1(5):198-202. doi: 10.1021/acsinfecdis.5b00017. Epub 2015 Mar 18.
2
Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection.受乳酸杆菌启发的四胺酸基序对甲硝唑进行胃肠道定位可改善艰难梭菌感染仓鼠模型的治疗效果。
J Antimicrob Chemother. 2015 Nov;70(11):3061-9. doi: 10.1093/jac/dkv231. Epub 2015 Aug 18.
3
Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile.
脆弱拟杆菌代谢中吡咯啉-5-羧酸还原酶的同系物及 2-酮戊二酸:铁氧还蛋白氧化还原酶对毕赤酵母蛋白新功能的影响及其对甲硝唑和氨曲南药敏性的影响
Microbiologyopen. 2024 Aug;13(4):e1429. doi: 10.1002/mbo3.1429.
4
Current and Ongoing Developments in Targeting Infection and Recurrence.针对感染和复发的当前及正在进行的进展。
Microorganisms. 2024 Jun 15;12(6):1206. doi: 10.3390/microorganisms12061206.
5
Repurposing Anthelmintics: Rafoxanide- and Copper-Functionalized SBA-15 Carriers against Methicillin-Resistant .抗蠕虫药物再利用:拉呋替丁和铜功能化 SBA-15 载体对抗耐甲氧西林金黄色葡萄球菌
ACS Appl Mater Interfaces. 2023 Apr 12;15(14):17459-17469. doi: 10.1021/acsami.2c19899. Epub 2023 Mar 28.
6
Investigation of Salicylanilides as Botulinum Toxin Antagonists.水杨酰苯胺类作为肉毒杆菌毒素拮抗剂的研究。
ACS Infect Dis. 2022 Aug 12;8(8):1637-1645. doi: 10.1021/acsinfecdis.2c00230. Epub 2022 Jul 25.
7
Double Repositioning: Veterinary Antiparasitic to Human Anticancer.双重定位:兽医驱虫药到人类抗癌药。
Int J Mol Sci. 2022 Apr 13;23(8):4315. doi: 10.3390/ijms23084315.
8
Drug repositioning: Progress and challenges in drug discovery for various diseases.药物重定位:各种疾病药物发现中的进展和挑战。
Eur J Med Chem. 2022 Apr 15;234:114239. doi: 10.1016/j.ejmech.2022.114239. Epub 2022 Feb 28.
9
Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics.新冠疫情期间的多药耐药危机:抗菌肽作为下一代治疗药物的作用。
Colloids Surf B Biointerfaces. 2022 Mar;211:112303. doi: 10.1016/j.colsurfb.2021.112303. Epub 2021 Dec 20.
10
Irritable Bowel Syndrome Therapeutic Has Broad-Spectrum Antimicrobial Activity.肠易激综合征治疗药物具有广谱抗菌活性。
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0044321. doi: 10.1128/AAC.00443-21. Epub 2021 Jul 19.
舒罗霉素对生长中和非生长艰难梭菌的作用模式及杀菌特性
Antimicrob Agents Chemother. 2015 Sep;59(9):5165-70. doi: 10.1128/AAC.01087-15. Epub 2015 Jun 8.
4
Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.舒洛托霉素对艰难梭菌体外生存能力及毒素产生的影响。
Antimicrob Agents Chemother. 2015 Jul;59(7):4199-205. doi: 10.1128/AAC.00275-15. Epub 2015 May 4.
5
Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.重新利用水杨酰苯胺类驱虫药来对抗耐甲氧西林金黄色葡萄球菌。
PLoS One. 2015 Apr 21;10(4):e0124595. doi: 10.1371/journal.pone.0124595. eCollection 2015.
6
Genome Resequencing of the Virulent and Multidrug-Resistant Reference Strain Clostridium difficile 630.致病性及多重耐药性艰难梭菌参考菌株630的全基因组重测序
Genome Announc. 2015 Apr 9;3(2):e00276-15. doi: 10.1128/genomeA.00276-15.
7
Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting.利用β-咔啉的多靶点药理学作用来干扰旋盘尾丝虫蜕皮。
ACS Med Chem Lett. 2015 Jan 20;6(3):339-43. doi: 10.1021/ml500516r. eCollection 2015 Mar 12.
8
Clostridium difficile drug pipeline: challenges in discovery and development of new agents.艰难梭菌药物研发进程:新型药物发现与开发面临的挑战
J Med Chem. 2015 Jul 9;58(13):5164-85. doi: 10.1021/jm5016846. Epub 2015 Mar 30.
9
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
10
Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting.双质子载体-几丁质酶抑制剂显著影响旋毛虫蜕皮。
J Med Chem. 2014 Jul 10;57(13):5792-9. doi: 10.1021/jm5006435. Epub 2014 Jun 20.